查詢結果分析
來源資料
相關文獻
- 再談減除白血球血小板的好處
- 減除白血球血品的實證醫學
- 自愛滋病患者結膜刮取物中培養出巨細胞病毒
- 愛滋病患合併巨細胞病毒視網膜炎之藥物治療及病例報告
- 愛滋病的視網膜病變
- 由巨細胞病毒視網膜炎診斷出愛滋病--病例報告
- Seroprevalence of CMV Antibodies in a Blood Donor Population and Premature Neonates in the South-Central Taiwan
- Dual Infection with Non-self-limited Cytomegalovirus and Shigella of the Colon in Non-immunocompromised Patient: Report of a Case
- Disseminated Cytomegalovirus Disease in a Patient with Systemic Lupus Erythematosus not Undergoing Immunosuppressive Therapy
- Perinatal Cytomegalovirus Infection Complicated with Pneumonitis and Adrenalitis in a Premature Infant
頁籤選單縮合
題名 | 再談減除白血球血小板的好處=Re-emphasize the Benefits of Leukocyte-reduced Platelets |
---|---|
作者姓名(中文) | 林東燦; 羅仕錡; | 書刊名 | 臺灣醫學 |
卷期 | 23:6 2019.11[民108.11] |
頁次 | 頁785-788 |
分類號 | 415.652 |
關鍵詞 | 減除白血球血小板; 輸血不良反應; 巨細胞病毒; 非溶血性發熱性輸血反應; 血小板輸注無效; Leukocyte-reduced platelets; Transfusion reaction; Cytomegalovirus; Non-hemolytic febrile transfusion reactions; Platelet transfusion refractoriness; |
語文 | 中文(Chinese) |
中文摘要 | 研究顯示輸注減除白血球血小板(減白血小板)可有效降低非溶血性發熱性輸血不良反應、巨細胞病毒感染及預防血小板輸注無效的發生,足以提昇輸血安全。此外,研究評估使用減白血小板可减少輸血不良反應的處置費用,更可以大幅降低因血小板輸注無效導致的血品費用。是以呼籲在台灣應放寬或解除輸用減白血小板的限制,以創造雙贏的局面。 |
英文摘要 | Substantial reports showed the evidenced-based effect of transfusion of leuko-reduced platelet concentrates (LRPC) including reduction of non-hemolytic febrile transfusion adverse reaction (NHFTR), CMV infection and prevention of occurrence of platelet transfusion refractoriness. Therefore, LRPC rather than platelet concentrates can improve transfusion safety definitely. Cost evaluation revealed that using LRPC can reduce total fee in dealing with NHFTR. In addition, another study showed that transfusion of LRPC can decrease the cost of management of platelet transfusion refractoriness dramatically. In this moment, we call for releasing or completely eliminating the limitation on the use of LRPC to create a win-win situation in Taiwan. |
本系統之摘要資訊系依該期刊論文摘要之資訊為主。